지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수3
1. 서 론 ·················································· 011.1 연구 배경 ·············································· 011.2 문헌 연구 ·············································· 091.2.1 지하수 내 비소 및 질산염 제거 기술 ······ 091.2.2 미생물학적 비소 및 질산염 산화 환원 특성···················································· 131.2.3 비소 및 질산염의 생물학적 동시 처리 연구동향 ·············································· 171.3 연구 목표 ·············································· 231.3.1 연구의 목적 ···································· 231.3.2 연구의 범위 ···································· 242. 연구 재료 및 방법 ··································· 252.1 습지 퇴적토 시료 채취 ······························ 252.2 탈질 및 비소 동시 산화 특성 회분식 배양 실험· 272.2.1 영향 인자 실험 ································ 272.2.1.1 미생물과 질산염 존재 영향 ········· 282.2.1.2 초기 질산염 농도 영향 ·············· 302.2.1.3 초기 비소 농도 영향 ················ 302.2.1.4 초기 아세테이트 농도 영향 ········ 302.2.2 재주입 실험(Re-spiking experiment) ······ 322.3 분석 방법 ············································· 332.3.1 배양 실험 시료 채취 ························· 332.3.2 상등액의 화학 분석···························· 332.3.3 XANES 분석··································· 342.3.4 DNA 추출 및 미생물 군집 분석 ··········· 352.3.5 qPCR 분석 ····································· 362.3.6 arxA 유전자 증폭 ····························· 383. 결과 및 고찰 ········································· 393.1 습지 미생물에 의한 질산염 환원과 비소 동시산화 특성··············································· 393.1.1 습지 퇴적토 및 질산염 존재 영향 ·········· 393.1.2 초기 질산염 농도의 영향 ···················· 483.1.3 초기 비소 농도의 영향 ······················· 513.1.4 초기 아세테이트 농도의 영향 ··············· 533.2 질소 환원 및 비소 동시 산화 반응 지속가능성평가 ······················································ 563.2.1 질소 환원 및 비소 동시 산화 특성 장기모니터링 ·········································· 563.2.2 배양 전후의 미생물 군집 특성 비교 ·········· 603.2.3 질산염 환원 및 비소 산화 유전자 정량화 ··· 653.3 화학양론식 및 미생물 유전자 분석을 통한 메커니즘 도출 ··············································· 724. 결론 ···················································· 77참고문헌 ····················································· 81
0